Jeffrey D. Capello holds the role of Director at AGIOS PHARMACEUTICALS, INC. (AGIO). Capello's filing history also covers NEOGEN CORP (NEOG). Capello has reported 12 insider filings with the SEC since 2024. The most recent filing was in June 2026.
Every role Jeffrey D. Capello has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
AGIOS PHARMACEUTICALS, INC. (AGIO)2 filingsUpdated Aug 30, 2026
Jeffrey D. Capello is Director of AGIOS PHARMACEUTICALS, INC. (AGIO). 12 SEC Form 4 filings on record going back to 2024, most recently on 23 June 2026. Most recent open-market trade: bought $100K of NEOG on 22 April 2025. Lifetime open-market purchases: $100K.
Every recent SEC Form 4 transaction Jeffrey D. Capello has reported, most recent first.
InsiderAlpha's records for Jeffrey D. Capello go back to 2024: 12 primary Form 4 filings, an average of 4.0 per year. The typical open-market purchase is $100K (1 buy totaling $100K). The largest single buy on record is $100K of NEOG in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey D. Capello files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Jeffrey D. Capello is a corporate insider, tracked as Director of AGIOS PHARMACEUTICALS, INC. (AGIO). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchase ($100K) and 0 open-market sales across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$NEOG NEOGEN CORP1.8K shares @ $6.19$11K